alfuzosin has been researched along with Nocturia in 2 studies
alfuzosin: structure given in first source
Nocturia: Frequent URINATION at night that interrupts sleep. It is often associated with outflow obstruction, DIABETES MELLITUS, or bladder inflammation (CYSTITIS).
Excerpt | Relevance | Reference |
---|---|---|
"To assess the 3-year efficacy and safety of the selective alpha(1)-blocker alfuzosin at 10 mg once daily in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in 'real-life practice'." | 7.74 | Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice. ( Alcaraz, A; Elhilali, M; Emberton, M; Hartung, R; Harving, N; Matzkin, H; Vallancien, G; van Moorselaar, RJ, 2008) |
"To assess the 3-year efficacy and safety of the selective alpha(1)-blocker alfuzosin at 10 mg once daily in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in 'real-life practice'." | 3.74 | Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice. ( Alcaraz, A; Elhilali, M; Emberton, M; Hartung, R; Harving, N; Matzkin, H; Vallancien, G; van Moorselaar, RJ, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Leungwattanakij, S | 1 |
Watanachote, D | 1 |
Noppakulsatit, P | 1 |
Petchpaibuol, T | 1 |
Choeypunt, N | 1 |
Tongbai, T | 1 |
Wanamkang, T | 1 |
Lojanapiwat, B | 1 |
Permpongkosol, S | 1 |
Tantiwong, A | 1 |
Pripatnanont, C | 1 |
Akarasakul, D | 1 |
Kongwiwatanakul, S | 1 |
Chotikawanich, E | 1 |
Vallancien, G | 1 |
Emberton, M | 1 |
Alcaraz, A | 1 |
Matzkin, H | 1 |
van Moorselaar, RJ | 1 |
Hartung, R | 1 |
Harving, N | 1 |
Elhilali, M | 1 |
1 trial available for alfuzosin and Nocturia
Article | Year |
---|---|
Sexuality and management of benign prostatic hyperplasia with alfuzosin: SAMBA Thailand.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Ejaculation; Erectile Dysfunction; Humans; Male; Midd | 2010 |
1 other study available for alfuzosin and Nocturia
Article | Year |
---|---|
Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
Topics: Adrenergic alpha-Antagonists; Aged; Disease Progression; Erectile Dysfunction; Humans; Male; Nocturi | 2008 |